Natco Pharma receives FDA report Kothur facility in India

Natco Pharma receives FDA report for Kothur facility in India

9:18 AM, 6th August 2019
Natco Pharma logo

HYDERABAD, INDIA: Natco Pharma Limited said that it has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its Kothur facility in Telangana, India.

The receipt indicates the successful closure of inspection of the company's drug formulations facility in Kothur, Natco Pharma said in a BSE filing.

Natco was established in Hyderabad, India in the year 1981 with an initial investment of Rupees 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has seven manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc.

Natco currently consists of around 5000 employees, and is constantly ranked among fastest growing pharmaceutical companies in India.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

AkzoNobel launches new digital Color Sensor

AMSTERDAM, NETHERLANDS: AkzoNobel NV has developed a new digital Color Sensor, helping professional painters to be more confident about precisely matc ...

Read more
Grace licenses Unipol technology to Chinese Coal Mine Group

COLUMBIA, US: W R Grace & Co has licensed its Unipol PP Process Technology to Datong Coal Mine Group Co Ltd. The Unipol PP facility, loc ...

Read more
Novel catalysis approach reduces carbon dioxide to methane

A growing number of scientists are looking for fast, cost-effective ways to convert carbon dioxide gas into valuable chemicals and fuels. Now, an int ...

Read more
SDK develops technology to directly bond aluminium alloys & polycarbonate resin

TOKYO, JAPAN: Showa Denko has developed an innovative technology to directly join/bond aluminium alloys and polycarbonate resin—a commodity amor ...

Read more
Cipla in talks to invest in e-pharmacy startup Medlife

BENGALURU/MUMBAI, INDIA: Drug major Cipla is in talks to invest in online healthcare platform Medlife, three people aware of the discussions said, in ...

Read more
Chemours acquires mining operations of Southern Ionics Minerals

WILMINGTON, US: The Chemours Company has acquired Southern Ionics Minerals LLC (SIM), a minerals exploration, mining, and manufacturing company headqu ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X